Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Annals of Neurology

• Publication date

  1990-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ana.410280413PMID 2252366
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The AIDS dementia complex and HIV-1 brain infection: a pathogenetic model of virus-immune interaction.

  1990cited by this paper
• Early HIV‐1 infection and the AIDS dementia complex

  1990cited by this paper
• Cerebrospinal fluid ß2 microglobulin in patients infected with human immunodeficiency virus

  1989cited by this paper
• Cerebrospinal fluid beta 2 microglobulin in patients infected with human immunodeficiency virus.

  1989cited by this paper
• Association between intrathecal anti-HIV-1 immunoglobulin G synthesis and occurrence of HIV-1 in cerebrospinal fluid.

  1989cited by this paper
• Elevated neopterin and beta 2-microglobulin levels in blood and cerebrospinal fluid occur early in HIV-1 infection.

  1989cited by this paper
• Serum neopterin changes in HIV-infected subjects: indicator of significant pathology, CD4 T cell changes, and the development of AIDS.

  1989cited by this paper
• Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1.

  1989cited by this paper
• HIV isolation from cerebrospinal fluid in relation to immunological deficiency and neurological symptoms.

  1988cited by this paper
• AIDS dementia complex.

  1988cited by this paper
• Inhibition of GTP cyclohydrolase I by pterins.

  1988cited by this paper
• The AIDS dementia complex.

  1988cited by this paper
• Neopterin as a marker for activated cell-mediated immunity: application in HIV infection.

  1988cited by this paper
• Early penetration of the blood‐brain‐barrier by HIV

  1988cited by this paper
• Cerebrospinal fluid abnormalities in homosexual men with and without neuropsychiatric findings

  1988cited by this paper
• Human immunodeficiency virus-associated meningitis. Clinical course and correlations.

  1987cited by this paper
• CSF protein and cellular profiles in various stages of HIV infection related to neurological manifestations.

  1987cited by this paper
• Determination of neopterin in serum and urine.

  1987cited by this paper
• The evils of delay.

  1987cited by this paper
• Neurologic abnormalities and recovery of human immunodeficiency virus from cerebrospinal fluid.

  1987cited by this paper
• Neopterin levels correlating with the Walter Reed staging classification in human immunodeficiency virus (HIV) infection.

  1987cited by this paper
• Intrathecal production of neopterin in aseptic meningo-encephalitis and multiple sclerosis.

  1987cited by this paper
• The AIDS dementia complex: II. Neuropathology

  1986cited by this paper
• Interferon-γ Enhances Biosynthesis of Pterins in Peripheral Blood Mononuclear Cells by Induction of GTP-Cyclohydrolase I Activity

  1986cited by this paper
• Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection.

  1986cited by this paper
• Urinary neopterin and biopterin levels in patients with AIDS and AIDS-related complex.

  1985influential reference
• Confidentiality and under-age girls who seek contraceptive advice.

  1983cited by this paper
• Pteridines in Cancer and Other Diseases

  1983cited by this paper
• CONCENTRATIONS OF CSF PROTEINS AS A MEASURE OF BLOOD BRAIN BARRIER FUNCTION AND SYNTHESIS OF IgG WITHIN THE CNS IN ‘NORMAL’ SUBJECTS FROM THE AGE OF 6 MONTHS TO 30 YEARS

  1981cited by this paper

• Neuropathogenesis of acute HIV: mechanisms, biomarkers, and therapeutic approaches

  2025cites this paper
• We are IntechOpen, the world’s leading publisher of Open Access books Built by scientists, for scientists

  2023cites this paper
• New Potential Axes of HIV Neuropathogenesis with Relevance to Biomarkers and Treatment.

  2020cites this paper
• HIV-Associated Neurocognitive Disorder (HAND)

  2020cites this paper
• Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals

  2018cites this paper
• CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study

  2018cites this paper
• HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment

  2017cites this paper
• HIV/neuroAIDS biomarkers

  2017influential citation
• 1 Biomarkers of Encephalitis

  2017influential citation
• Clinical Relevance of Total HIV DNA in Peripheral Blood Mononuclear Cell Compartments as a Biomarker of HIV-Associated Neurocognitive Disorders (HAND)

  2017cites this paper
• Tryptophan Metabolism and Its Relationship with Depression and Cognitive Impairment Among HIV-infected Individuals

  2016cites this paper
• Non-reliability of Beta-2 Microglobulin and Neopterin as Short-term Immunological Markers of HIV Progression

  2016cites this paper
• Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study

  2016cites this paper
• Utility of CSF Cytokine/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral Encephalitis

  2016cites this paper
• Cell-free mitochondrial DNA in CSF is associated with early viral rebound, inflammation, and severity of neurocognitive deficits in HIV infection

  2015cites this paper
• Viral and inflammatory markers in cerebrospinal fluid of patients with HIV‐1‐associated neurocognitive impairment during antiretroviral treatment switch

  2015cites this paper
• Loss of CCR2 expressing non-classical monocytes are associated with cognitive impairment in antiretroviral therapy-naïve HIV-infected Thais.

  2015cites this paper
• ReviewCerebrospinal fluid neopterin : an informative biomarker of central nervous system immune activation in HIV-1 infection

  2015cites this paper
• Clinical Aspects of HIV‐Related Neurocognitive Disorders

  2014cites this paper
• HIV-associated neuropathogenesis: A systems biology perspective for modeling and therapy

  2014cites this paper
• Central nervous system HIV-1 infection.

  2014cites this paper
• HIV-associated neurocognitive disorder.

  2013cites this paper
• Antiviral activity of interferon-γ involved in impaired immune function in infectious diseases

  2013cites this paper
• A Biological Perspective of CSF Lipids as Surrogate Markers for Cognitive Status in HIV

  2013cites this paper
• Neurotoxicity of antiretroviral therapy

  2013cites this paper
• Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy

  2013cites this paper
• Immune activation and neuropsychiatric symptoms in human immunodeficiency virus type 1 infection

  2012cites this paper
• HIV Encephalopathy - Now and Then

  2012cites this paper
• Predictors of Hiv-related Neurocognitive Impairment in an Hiv/aids Population

  2012cites this paper
• Monocyte Activation Markers in Cerebrospinal Fluid Associated With Impaired Neurocognitive Testing in Advanced HIV Infection

  2012cites this paper
• HIV-1 Nef in Macrophage-Mediated Disease Pathogenesis

  2012cites this paper
• Review of Antiretroviral Therapy in the Prevention of HIV-Related AIDS Dementia Complex (ADC)

  2012cites this paper
• The Central Nervous System Manifestations of HIV-1 Infection in the Combination Antiretroviral Therapy Era

  2011cites this paper
• Biomarkers of Encephalitis

  2011influential citation
• HIV-1 Replication in the Central Nervous System Occurs in Two Distinct Cell Types

  2011cites this paper
• Increased blood-brain barrier permeability in neuro-asymptomatic HIV-1-infected individuals—correlation with cerebrospinal fluid HIV-1 RNA and neopterin levels

  2011influential citation
• A guide to interpretation of neuroimmunological biomarkers in the combined antiretroviral therapy-era of HIV central nervous system disease

  2010cites this paper
• Human immunodeficiency virus‐associated neurocognitive disorders: Mind the gap

  2010cites this paper
• Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder

  2010cites this paper
• HIV-1 subtype B determinants of neuropathogenesis: viral characteristics associated with dementia

  2010cites this paper
• Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection

  2010influential citation
• Antioxidant enzyme dysfunction in monocytes and CSF of Hispanic women with HIV-associated cognitive impairment.

  2009cites this paper
• Cerebrospinal fluid markers in the management of central nervous system HIV infection and the AIDS dementia complex.

  2009cites this paper
• Global Issues in Neuro-AIDS and Their Evolution over the Future of the HAART Era

  2009cites this paper
• Compartmentalization and Clonal Amplification of HIV-1 Variants in the Cerebrospinal Fluid during Primary Infection

  2009cites this paper
• Biomarkers of HIV-1-associated neurocognitive disorders: challenges of proteomic approaches.

  2009cites this paper
• Chemokines and the Neuropathogenesis of HIV-1 Infection

  2009cites this paper
• Compartmentalized Human Immunodeficiency Virus Type 1 Originates from Long-Lived Cells in Some Subjects with HIV-1–Associated Dementia

  2009cites this paper
• Estimation of virological and immunological parameters in subjects from South India infected with human immunodeficiency virus type 1 clade C and correlation of findings with occurrence of neurological disease

  2009cites this paper
• Mode of Coreceptor Use by R5 HIV Type 1 Correlates with Disease Stage: A Study of Paired Plasma and Cerebrospinal Fluid Isolates

  2009cites this paper
• Involvement of quinolinic acid in aids dementia complex

  2009cites this paper
• Preventing brain damage in HIV infection

  2008cites this paper
• Antiretroviral therapy and central nervous system HIV type 1 infection.

  2008cites this paper
• Biomarkers of HIV related central nervous system disease

  2008influential citation
• AIDS dementia complex.

  2007cites this paper
• Indoleamine-2, 3-dioxygenase and other interferon-gamma-mediated pathways in patients with human immunodeficiency virus infection.

  2007cites this paper
• CSF neurofilament protein (NFL) — a marker of active HIV-related neurodegeneration

  2007cites this paper
• Defining and Evaluating HIV-Related Neurodegenerative Disease and Its Treatment Targets: A Combinatorial Approach to Use of Cerebrospinal Fluid Molecular Biomarkers

  2007cites this paper
• Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection

  2007cites this paper
• Biomarkers of HIV-1 CNS infection and injury

  2007cites this paper
• Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex.

  2007cites this paper
• Estudio de los cambios virológicos y de inmunidad celular en tejido amigdalar tras tratamiento antiretroviral en pacientes infectados por HIV en estado temprano de la infección

  2007cites this paper
• Chemokines and Their Receptors and the Neuropathogenesis of HIV-1 Infection

  2006cites this paper
• Neopterin in HIV-1 infection.

  2005cites this paper
• Influencia de las variables clínico-biológicas CD4 y carga viral sobre el rendimiento neuropsicológico de pacientes con infección por VIH-1

  2005cites this paper
• HAART & the molecular biology of AIDS dementia complex.

  2005cites this paper
• Examen critique Neuropsychiatric manifestations of HIV infection and AIDS

  2005cites this paper
• The AIDS dementia complex: Clinical and basic Neuroscience with implications for novel molecular therapies

  2005cites this paper
• Neurological complications of HIV infection.

  2005cites this paper
• Cerebrospinal fluid HIV viral load in different phases of HIV–associated brain disease

  2005cites this paper
• Cerebrospinal fluid proteomics and human immunodeficiency virus dementia: Preliminary observations

  2005cites this paper
• Neuropsychiatric manifestations of HIV infection and AIDS.

  2005cites this paper
• Expansion of neopterin and beta2-microglobulin in cerebrospinal fluid reaches maximum levels early and late in the course of human immunodeficiency virus infection

  2004cites this paper
• Assessing the Efficacy of Highly Active Antiretroviral Therapy in the Brain

  2003cites this paper
• HIV Infection, Neurological Complications of

  2003cites this paper
• Potential role of immune system activation-associated production of neopterin derivatives in humans

  2003cites this paper
• Human immunodeficiency virus-associated dementia: An evolving disease

  2003cites this paper
• Human immunodeficiency virus dementia: evidence of a subcortical process from studies of fine finger movements.

  2002influential citation
• AIDS dementia.

  2002cites this paper
• Pathogenesis and Clinical Manifestations of HIV-1 Infection

  2002cites this paper
• Neuroimmune and neurovirological aspects of human immunodeficiency virus infection.

  2001cites this paper
• Chapter 12 Clinical Trials in Central Nervous System Infections

  2001cites this paper
• Anatomical and cellular reservoirs for HIV-1 during potent antiretroviral therapy

  2001cites this paper
• Reduced pteridine derivatives induce apoptosis in human neuronal NT2/HNT cells.

  2000cites this paper
• Increasing Cerebrospinal Fluid Chemokine Concentrations Despite Undetectable Cerebrospinal Fluid HIV RNA in HIV‐1‐Infected Patients Receiving Antiretroviral Therapy

  2000cites this paper
• HIV-1-associated central nervous system dysfunction.

  2000cites this paper
• Clinical and immunological significance of neopterin measurement in cerebrospinal fluid in patients with febrile convulsions.

  1999cites this paper
• The neuropathogenesis of HIV-1 infection.

  1999cites this paper
• AIDS dementia complex.

  1999cites this paper
• The neuropathogenesis of HIV-1 infection.

  1999cites this paper
• Clinical Features and Treatment Interventions for Human Immunodeficiency Virus-Associated Neurologic Disease in Children

  1999cites this paper
• Cerebrospinal Fluid Levels of Neopterin in Child Patients with Neurological Diseases-In Correlation with IFN-γ or TNF-α

  1999cites this paper
• Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection.

  1999cites this paper
• Randomized trial of the platelet-activating factor antagonist lexipafant in HIV–associated cognitive impairment

  1999cites this paper
• HIV-assoziierte neurologische Erkrankungen

  1999cites this paper
• Human Immunodeficiency Virus-Associated Dementia

  1999cites this paper
• Neopterin concentrations in cerebrospinal fluid and serum as an aid in differentiating central nervous system and peripheral infections in children.

  1998cites this paper
• [Pathophysiology of HIV-1 infection of the nervous system and AIDS- related dementia].

  1998cites this paper
• Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine.

  1998cites this paper
• A phase I/II trial of nimodipine for HIV-related neurologic complications

  1998cites this paper